Prostatic acid phosphatase (EC 3.1.3.2) purified from benign hypertrophic prostate tissue was fractionated by preparative slab isoelectric focusing over a pH gradient of 3.16 to 7.16. Twenty-two of 29 fractions contained enzyme activity. We further examined each active fraction by determining the Michaelis-Menten constant and specific activity. The protein concentration used in the latter determination was estimated either spectrophotometrically or immunochemically by three different radioimmunoassays for the enzyme. Determination of specific activities for each fraction directly correlated enzyme activity with an immunochemical determination, which indicated the immunochemical relationships among different molecular species of the enzyme. We found that the Michaelis-Menten constants for the isolated fractions were similar to the Km value for purified, unfractionated enzyme. Most fractions analyzed by each immunoassay had similar specific activities; the few fractions with discrepant specific activities were found at either end of the pH gradient. The similarity in specific activities among the fractions indicates that RIAs involving polyclonal antisera detect all of the electrophoretic variants of the enzyme. 
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Materials and Methods
Purification 1.5 mL of pH 3.5-5 Ampholine, and 1.5 mL of pH 4-6 Ampholine (LKB Instruments).
Duplicate gels were prepared and run at 1 #{176}C, with the same power supply, for 3 h at 25 W constant power. One gel was stained for protein with Coomassie Blue; the other was stained for enzyme activity with a-naphthyl phosphate-Fast Garnet salt (oaminoazotoluene, diazonium salt) as described by Lee et al.
(8).

Preparative IEF of Purified PAP
To prepare the Sephadex G-75 (Pharmacia Fine Chemicals, Piscataway, NJ 08854) ampholyte slurry, we added 2.5 mL of pH [5] [6] [7] Ampholine, 1.25 mL of pH 4-6 Ampholine, and 1.25 mL of pH 3. pressure, we added 9.84 mg of purified PAP in 1.3 mL of glycine (10 g/L), then poured the slurry into a template according to the manufacturer's instructions (LKB Application Note 198). We then placed the template on the Multiphor apparatus and ran the gel at 1 #{176}C at 8 W constant power for 25 h. The gel bed was divided with a fractionating grid (LKB Instruments) into 29 chambers (1 x 10.5 cm). We kept only the center two-thirds of the gel, to minimize contamination between chambers owing to edge effects. The ampholyte solution in each chamber was separated from the Sephadex gel by filtration through silk mesh in a Model FH 225 ifitration apparatus (Hoeffer Scientific Instruments, San Francisco, CA 94107), then pooled with 6 mL of water wash of the gel before we determined the pH for each fraction at 0#{176}C. The isolated fractions were dialyzed for two days at 4#{176}C, against sodium acetate buffer (20 mmol/L, pH 5.2) with two 16-L changes of buffer, and simultaneously concentrated by reduced pressure. The apparatus for this procedure was the bottom portion of a large vacuum dessicator equipped with a Plexiglass top. Multiple holes were drilled in the Plexiglass to accommodate one-hole rubber stoppers, through which glass tubes were passed and tied to dialysis sacks (dialysis tubing with one end tied). Each fraction of PAP was transferred into a separate sack and the pressure was reduced by connecting a glass tube with no dialysis sack to a laboratory vacuum line. Each concentrated fraction (0.8 mL) was centrifuged to remove any residual fine particles of Sephadex and stored at -70 #{176}C until further analysis.
Complete analysis could not be performed on every fraction because of limitations in the amount of protein.
Determination of Km
We determined the Michaelis. The concentration of protein in each fraction was determined either spectrophotometrically as discussed above (10)
Determination of Specific Activity
or by three RIAs for PAP. In two of the RIAs described earlier (16) were used two different anti-PAP antisera (R-102 and R-109), prepared in rabbits with PAP isolated from prostate tissue as antigen. The bound tracer was separated from the free tracer by the use of 100 g/L polyethylene glycol (Polyethylene Glycol 6000; Fisher Scientific Co., Fair Lawn, NJ 07410) as described previously (17) . The other RIA was the "Rianen PAP" assay kit (New England Nuclear, Boston, MA 02118), in which was used a goat antibody against purified PAP isolated from seminal fluid.
Each sample was assayed in duplicate at three concentrations. The specific activity for each fraction was calculated by dividing the catalytic activity concentration (in U/mL) by the average concentration of PAP (in gIL), as determined by the four methods described above.
Results
Purification of PAP and Preparative lEE
We recovered 24.24 mg of purified PAP from 1514 mg of protein in a crude tissue homogenate. Of the total enzymic activity in this homogenate, 61% was accounted for as purified enzyme with a specific activity of 400 U/mg of protein.
As Figure 1 shows, the pattern of protein staining of the purified enzyme on the sodium dodecyl sulfate acrylamide gel (i.e., the second gel in the procedure) was similar to that described earlier (16, 18), and confirmed the high degree of purity of the preparation. The p1 values for the proteins were 5.6 to 6.3 in 9 mol/L urea, with an apparent molecular mass of approximately 48 000 Da.
Fractionation of 9.8 mg of purified
PAP over a pH gradient of 3.16 to 7.16 in preparative IEF showed that 22 of the 29 fractions contained enzyme activity. The major fractions of enzyme activity were eluted between pH 4.6 to 5.4 and 5.9 to 6.3 ( Figure 2) . The analytical recovery of PAP from the preparative IEF procedure was 34%, as determined by enzymic activity or by absorbance at 280 nm. Purified PAP or fractions of purified PAP recovered after preparative IEF were characterized by analytical IEF. Two gels were run, one stained for enzymic activity, the other for protein.
Fig. 1. Two-dimensional gel electrophoresis of purified PAP
The gel stained for enzymic activity (Figure 3) showed more bands than that stained for protein, even though it contained 36-to 113-fold less protein. The results in Figure 3 show that the bands of enzymic activity in each fraction correlated with bands found in the unfractionated, purified PAP sample, indicating that there was no selective loss or modification of the electrophoretic variants during the fractionation procedure. Isolated subsets of these variants could not be obtained because of the large number of electrophoretic forms.
Analysis of Fractions Isolated by Preparative IEF
The Michaelis-Menten constant for fractions recovered after preparative IEF ranged from 77 to 125 jmolIL; the Km for the unfractionated purified PAP was 87 mol/L. Figure 4 shows the specific activities of each fraction. These values are derived from a determination of enzyme activity and four different determinations of protein concentration. In general, specific activities calculated for the same fraction agree well. Markedly increased values for specific activities were obtained in fractions at either end of the pH range (i.e., fractions 5 and 28). In contrast, similar results were not obtained when these fractions were assayed with R-109 antisera.
DIscussion
This report confirms and extends observations enzyme (2, 5, 15, 20) . Isolation of two fractions of purified enzyme by chromatography on diethylaminoethyl-cellulose showed that the fractions containing molecules with fast electrophoretic mobility had 30% more sialic acid residues per mole of protein than did fractions containing the slower. enzyme (20) . Moreover, neuraminidase removed about 80% of the sialic acid residues from the enzyme. We also determined the specific activity of the enzyme in each fraction, so that we could correlate enzymic activity with immunochemical measurement, a correlation that was not made in earlier reports examining the immunological identity of different fractions of enzyme. Moreover, in the earlier studies, antigenic identity was shown primarily by immunodiffusion tests, qualitative procedures that detect antibodies with broad range of affinity, whereas RIAs are quantitative procedures involving high-affinity antibodies. In the few fractions for which the RIAs indicated discrepant specific activities, such results were found at either end of the pH gradient and in only two of the three RIAs we used to quantify the enzyme. These discrepant results probably reflect differences in the specificity of the antibody because another antiserum, R-109, showed similar specific activities with fractions at either end of the gradient.
We conclude that there is similarity in enzyme activity and immunological identity among the different electrophoretic variants of PAP isolated from hypertrophic prostatic tissue. Further studies similar to the ones reported here are needed on serum from patients with prostate carcinoma, to further assess the effect of the degree of sialylation on antibody reactivity and quantitation by immunoassay.
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